英矽智能与齐鲁制药达成总额9.31亿港元药物研发合作 (IMAGE)

InSilico Medicine

英矽智能与齐鲁制药达成总额9.31亿港元药物研发合作

Caption

将依托英矽智能自有Pharma.AI解决方案，针对特定靶点开展小分子抑制剂合作开发，关注心血管与代谢类疾病领域管理。

Credit

英矽智能

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.